期刊文献+

11例瘤源性骨软化症的临床诊治分析 被引量:5

Clinical diagnosis and treatment of tumor-induced osteomalacia: An analysis of 11 cases
下载PDF
导出
摘要 目的分析瘤源性骨软化症(tumor—induced osteomalacia,TIO)的临床特征、诊断及治疗规律,提高对TIO的识别及早期诊治能力。方法我院2010年4月-2013年4月收治11例确诊TIO患者,分析其手术前、后临床症状及血生化变化情况。结果男性5例,女性6例;年龄19—54岁,平均37.7岁。发病到确诊的时间2—15年,平均5.5年。11例均有骨痛和肌无力症状,血磷低而尿磷高,血钙正常,碱性磷酸酶(alkaline phosphatase,ALP)升高。3例发现皮下软组织包块。8例行奥曲肽扫描(99m Tc—OCT)均提示有生长抑素受体高表达病变。11例手术治疗后均获得病理确诊,术后10例血磷恢复正常,所有患者骨痛及肌无力症状明显缓解。结论TIO临床症状典型,99m Tc—OCT及其他影像学检查有助于定位肿瘤。手术切除病灶后血磷可恢复正常,症状改善明显。 Objective To improve the clinical diagnosis and treatment level of tumor-induced osteomalacia (TIO) by analyzing the clinical features, diagnosis and treatment of 11 cases with TIO. Methods Clinical data (including clinical presentation, management, perioperative clinical status and biochemical changes) of 11 patients with TIO admitted to our hospital from April 2010 to April 2013 were retrospectively analyzed. Results There were 5 males and 6 females with an average age of 37.7 years (range 19-54 years). The average time interval between onset and proven TIO was 5.5 years (range, 2-15 years). All the 11 patients presented with bone pain and muscle weakness, hypophosphatemia, hyperphosphatemia, normal serum calcium and increased alkaline phosphatase (ALP). Subcutaneous soft tissue mass was found in 3 cases, 99mTc-OCT was performed in another 8 cases and it showed high expression of somatostatin receptor on different lesions of different patients. All the patients were confirmed by histopathology after operation. Serum Pi levels returned to normal in 10 patients after resection of tumors, symptoms of bone pain and muscle weakness were all improved obviously. Conclusion TIO is an extremely rare acquired disease with typical clinical features. Identifying the responsible tumors is clinically essential for the treatment of TIO, 99mTc-OCT and other imaging examinations are also helpful to locate the tumors. After complete excision of the tumors, the patients' serum phosphate levels and clinical symptoms are greatly improved.
出处 《解放军医学院学报》 CAS 2014年第7期707-709,750,共4页 Academic Journal of Chinese PLA Medical School
关键词 瘤源性骨软化症 低血磷 奥曲肽扫描 tumor-induced osteomalacia hypophosphatemia 99mTc-octreotide scintigraphy
  • 相关文献

参考文献2

二级参考文献59

  • 1DiMeglio LA,White KE,Econs MJ.Disorders of phosphate metabolism.Endocrinol Metab Clin North Am 2000; 29:591-609.
  • 2Shimada T,Mizutani S,Muto T,Yoneya T,Hino R,Takeda S,et al.Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.Proc Natl Acad Sci U S A 2001; 98:6500-6505.
  • 3Xia W,Meng X,Jiang Y,Li M,Xing X,Pang L,et al.Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets.Calcif Tissue Int 2007; 81:415-420.
  • 4Walton RJ,Bijvoet OL.Nomogram for derivation of renal threshold phosphate concentration.Lancet 1975; 2:309-310.
  • 5Sommer S,Berndt T,Craig T,Kumar R.The phosphatonins and the regulation of phosphate transport and vitamin D metabolism.J Steroid Biochem Mol Biol 2007; 103:497-503.
  • 6Shaikh A,Berndt T,Kumar R.Regulation of phosphate homeostasis by the phosphatonins and other novel mediators.Pediatr Nephrol 2008; 23:1203-1210.
  • 7Riminucci M,Collins MT,Fedarko NS,Cherman N,Corsi A,White KE,et al.FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.J Clin Invest 2003; 112:683-692.
  • 8Yamazaki Y,Okazaki R,Shibata M,Hasegawa Y,Satoh K,Tajima T,et al.Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.J Clin Endocrinol Metab 2002; 87:4957-4960.
  • 9Jonsson KB,Zahradnik R,Larsson T,White KE,Sugimoto T,Imanishi Y,et al.Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.N Engl J Med 2003:348:1656-1663.
  • 10Shimada T,Urakawa I,Yamazaki Y,Hasegawa H,Hino R,Yoneya T,et al.FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type Ila.Biochem Biophys Res Commun 2004; 314:409-414.

共引文献20

同被引文献36

  • 1姜艳,夏维波,邢小平,李梅,王鸥,张化冰,付勇,景红丽,李方,钟定荣,金今,周炼,亓放,李汉忠,孟迅吾.肿瘤性骨软化症的诊断及治疗[J].中国医学科学院学报,2010,32(4):477-478. 被引量:11
  • 2张化冰,潘慧,李方,夏维波,邢小平,孟迅吾.奥曲肽显像诊断肿瘤性骨软化一例[J].中华医学杂志,2005,85(33):2375-2376. 被引量:13
  • 3余卫,林强,张云庆,姜波,金今,姜艳,李梅,李方.瘤源性骨质软化症的影像学表现及临床诊断价值[J].中华放射学杂志,2006,40(6):616-620. 被引量:7
  • 4高增鑫,邱贵兴,翁习生,费琦,汪学松,刘正.尿磷性间叶肿瘤探究[J].中华外科杂志,2006,44(24):1722-1723. 被引量:3
  • 5蔡胜,袁岩,姜玉新,李方,余卫,戴晴,有慧,李建初.瘤原性佝偻病致病肿瘤的影像定位诊断[J].中国医学影像技术,2006,22(12):1873-1876. 被引量:7
  • 6Breer S, Brunkhorst T, Bell FT, et al. 68Ga DOTA- TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111 In-octreo- tide SPECT/CT[J]. Bone, 2014, 64: 222-722.
  • 7Mc CR. Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D ac- qui.'ed about the age of 15 years[J]. Q J Med, 1947, 16 ( 1 ): 33-46.
  • 8Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteo- malacia: an important cause of adult-onset hypophospha- temic osteomalacia in China: report of 39 cases and re- view of the literature[J]. J Bone Miner Res, 2012, 27(9): 1967-1975.
  • 9Weidner N, Santa Cruz D. Phosphaturic mesenchymal tu- mors. A polymorphous group causing osteomalacia or rickets[J]. Cancer, 1987, 59(8): 1442-1454.
  • 10Reubi JC, Waser B, Laissue JA, et al. Somatostatin and vasoactive intestinal peptide receptors in human mescn- chymal tumors: in vitro identification[J]. Cancer re- search, 1996, 56(8): 1922-1931.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部